Dr. Juliet E. Wolford, MD

Dr. Wolford practices at Kettering Independent Medical Group Inc in Dayton, Ohio.

Dr. Wolford's NPI, 1497002232, was assigned on August 11, 2012. Dr. Wolford holds Ohio license 35.139782.

Dr. Wolford's primary practice is Kettering Independent Medical Group Inc, at 3700 Southern Blvd, Dayton, OH 45429 in Montgomery County. The practice phone is (937) 762-1629.

Dr. Wolford's primary practice is Kettering Independent Medical Group Inc in Dayton, Ohio. Dr. Wolford is also affiliated with Miami Valley Hospital. The medical group on file is University of Cincinnati Physicians. Dmand AI also links Dr. Wolford to 4 more hospitals, 4 medical groups, 3 group practices and clinics and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wolford practices, 9 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Wolford's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dmand AI has Dr. Wolford's licenses on file in 2 states: Ohio and California.

CMS data shows 249 Medicare services from Dr. Wolford across 8 procedure codes in 2024, for 112 Medicare patients. Medicare paid $20,932 for them.

CMS counts 112 Medicare patients who saw Dr. Wolford in 2024. The largest group is 65 to 74, with 55 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wolford's median patient age at 64, with 99% women.

In 2024, Dr. Wolford wrote 478 Medicare Part D claims for 86 patients. 83% of them were for generic drugs. CMS names the drug for 384 of them, across 14 drugs with 11 or more claims each, at $927,311 in total drug cost. In 2023, CMS named 326 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Wolford for performance year 2024, reported as part of a group. Dr. Wolford accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 21 procedures of removal of the uterus by Dr. Wolford, more than 93% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 12 papers to Dr. Wolford, published from 2013 to 2024. 2019 was the busiest year, with 2. The most frequent topics are Ovarian Neoplasms, Genital Neoplasms, Female and Poly(ADP-ribose) Polymerase Inhibitors. Dr. Wolford has published most often in Gynecol Oncol Rep. Dr. Wolford's most frequent co-authors are Krishnansu Sujata Tewari, MD, Kiran H. Clair and Robert E. Bristow, MD.

Dmand AI links Dr. Wolford to 1 clinical trial. Conditions studied include Pre-Eclampsia and Hypertension, Pregnancy-Induced.

CMS Open Payments shows 80 general payments to Dr. Wolford from 13 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 63% of the total. Abbvie Inc. paid the most, $5,202.